Celanese Corp income statement
In fiscal 2025, Celanese Corp reported revenue of $9.54bn, down 7.1% on the year before, operating income of −$786m (a -8.2% margin) and net income of −$1.17bn, or −$10.64 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.1 | 5.9 | 6.8 | 6.4 | 6.5 | 6.8 | 5.7 | 5.4 | 6.1 | 7.2 | 6.3 | 5.7 | 8.5 | 9.7 | 10.9 | 10.3 | 9.5 | 9.7 |
| Cost of revenue | 4.1 | 4.7 | 5.3 | 5.2 | 5.1 | 5.2 | 4.4 | 4.0 | 4.6 | 5.2 | 4.7 | 4.4 | 5.9 | 7.3 | 8.3 | 7.9 | 7.6 | 7.7 |
| Gross profit | 1.0 | 1.2 | 1.4 | 1.2 | 1.4 | 1.6 | 1.3 | 1.4 | 1.5 | 2.0 | 1.6 | 1.3 | 2.7 | 2.4 | 2.6 | 2.3 | 2.0 | 2.0 |
| Research and development | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Selling, general and administrative | 0.5 | 0.5 | 0.8 | 0.8 | 0.3 | 0.8 | 0.5 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.8 | 1.1 | 1.0 | 0.9 | 0.9 |
| Operating income | 0.3 | 0.5 | 0.4 | 0.2 | 1.5 | 0.8 | 0.3 | 0.9 | 0.9 | 1.3 | 0.8 | 0.7 | 1.9 | 1.4 | 1.7 | −0.7 | −0.8 | −0.7 |
| Interest expense | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | 0.7 | 0.7 | 0.7 | 0.7 |
| Income before tax | 0.3 | 0.5 | 0.5 | 0.3 | 1.6 | 0.9 | 0.5 | 1.0 | 1.1 | 1.5 | 1.0 | 2.3 | 2.2 | 1.4 | 1.2 | −1.0 | −1.2 | −1.1 |
| Income tax | −0.2 | 0.1 | 0.0 | −0.1 | 0.5 | 0.3 | 0.2 | 0.1 | 0.2 | 0.3 | 0.1 | 0.2 | 0.3 | −0.5 | −0.8 | 0.5 | −0.1 | 0.0 |
| Net income | 0.5 | 0.4 | 0.4 | 0.4 | 1.1 | 0.6 | 0.3 | 0.9 | 0.8 | 1.2 | 0.9 | 2.0 | 1.9 | 1.9 | 1.9 | −1.5 | −1.2 | −1.2 |
| Diluted EPS | $3.17 | $2.38 | $2.69 | $2.33 | $6.91 | $4.00 | $2.00 | $6.18 | $6.09 | $8.91 | $6.84 | $16.75 | $16.86 | $17.34 | $17.76 | −$14.11 | −$10.64 | −$10.65 |
| Diluted shares (average) | 157m | 158m | 159m | 160m | 159m | 156m | 152m | 146m | 138m | 135m | 125m | 118m | 112m | 109m | 109m | 109m | 110m | 110m |
| EBITDA | 0.6 | 0.8 | 0.7 | 0.5 | 1.8 | 1.1 | 0.7 | 1.2 | 1.2 | 1.7 | 1.2 | 1.0 | 2.3 | 1.8 | 2.4 | 0.1 | −0.0 | 0.1 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,648 | 2,358 | 2,389 | 2,532 | 2,419 | 2,204 | 2,337 | 2,752 |
| Cost of revenue | 2,029 | 1,832 | 1,915 | 1,998 | 1,898 | 1,781 | 1,869 | 2,134 |
| Gross profit | 619 | 526 | 474 | 534 | 521 | 423 | 468 | 618 |
| Research and development | 32 | 31 | 31 | 31 | 31 | 32 | 28 | 29 |
| Selling, general and administrative | 248 | 263 | 231 | 214 | 231 | 223 | 226 | 251 |
| Operating income | 245 | −1,419 | 165 | 231 | −1,275 | 93 | 214 | 276 |
| Interest expense | 169 | 164 | 170 | 177 | 177 | 177 | 183 | 186 |
| Income before tax | 180 | −1,533 | −6 | 133 | −1,360 | 13 | 82 | 142 |
| Income tax | 61 | 384 | 9 | −77 | −7 | −15 | 33 | 11 |
| Net income | 113 | −1,925 | −24 | 197 | −1,357 | 19 | 44 | 125 |
| Diluted EPS | $1.03 | −$17.61 | −$0.22 | $1.80 | −$12.39 | $0.17 | $0.40 | $1.13 |
| EBITDA | 448 | −1,234 | 345 | 421 | −1,081 | 289 | 415 | 520 |
Compare with peers
More: Diversified Chemicals stocks compared, Materials sector, rankings of US companies